Rheumatologic Disorders
Disease State Hub
Featured
04/18/2024
A 24-year-old woman presented to the emergency department (ED) with joint swelling, severe arthralgias, and myalgias. She works as a nurse in a busy ED. She was admitted to the hospital for further workup.
...
04/18/2024
04/09/2024
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
04/09/2024
04/05/2024
In this video, Robert Terkeltaub, MD, gives an overview of the current standard of care in the treatment of individuals with gout.
04/05/2024
Interactive Features
04/09/2024
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
04/09/2024
01/29/2024
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Let us know by taking this quick poll!
01/29/2024
10/20/2023
When managing patients with psoriatic arthritis who do not respond to tumor necrosis factor inhibitors, clinicians must consider several factors before changing their treatment. Think you know what they...
10/20/2023
05/29/2023
Are you familiar with the latest recommendations from the European League Against Rheumatism on the treatment of skin and lung manifestations in individuals with systemic sclerosis? Take this pop quiz and...
05/29/2023
04/08/2023
How high is the risk of developing scleroderma among twins and family members of those with the condition? Take the quiz and find out!
04/08/2023
Clinical Insights
04/05/2024
In this video, Robert Terkeltaub, MD, gives an overview of the current standard of care in the treatment of individuals with gout.
04/05/2024
12/28/2023
In this podcast, Anand Kumthekar, MD, reviews the challenges and approaches to management of patients with difficult-to-treat psoriatic arthritis, including managing non-skin related manifestations of...
12/28/2023
12/11/2023
Cécile Philippoteaux, MD, MSc, PharmD
Cécile Philippoteaux, MD, MSc, PharmD
In this expert Q&A, Cécile Philippoteaux, MD, MSc, PharmD, discusses the results of her team’s recent review, including the prevalence, characteristics, definition, and the next steps for research in...
12/11/2023
11/09/2023
In this video, Robert Terkeltaub, MD, discusses his team's latest research on the pathophysiology of gout and a potential pathway for treatment by way of a molecule called lubricin in patients with gout who...
11/09/2023
10/20/2023
In this video, Robert Terkeltaub, MD, discusses classifying gout as acute or chronic, and how treatment should be tailored for each patient based on disease severity and characteristics as well as other...
10/20/2023
